224 related articles for article (PubMed ID: 6685149)
1. Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study.
Kawai C; Yui Y; Hoshino T; Sasayama S; Matsumori A
J Am Coll Cardiol; 1983 Nov; 2(5):834-40. PubMed ID: 6685149
[TBL] [Abstract][Full Text] [Related]
2. Myocardial catecholamines in primary heart muscle disease: fact or fancy?
Seferović PM; Maksimović R; Ostojić M; Stepanović S; Nikolić J; Vasiljević JD; Kanjuh V; Seferović D; Simeunović S; Ristić A
Eur Heart J; 1995 Dec; 16 Suppl O():124-7. PubMed ID: 8682078
[TBL] [Abstract][Full Text] [Related]
3. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy.
Ohtani K; Yutani C; Nagata S; Koretsune Y; Hori M; Kamada T
J Am Coll Cardiol; 1995 Apr; 25(5):1162-9. PubMed ID: 7897130
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease].
Regitz V; Sasse S; Bossaller C; Strasser R; Schüler S; Hetzer R; Fleck E
Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916
[TBL] [Abstract][Full Text] [Related]
6. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
7. Relationship between myocardial norepinephrine content and left ventricular function--an endomyocardial biopsy study.
Schofer J; Tews A; Langes K; Bleifeld W; Reimitz PE; Mathey DG
Eur Heart J; 1987 Jul; 8(7):748-53. PubMed ID: 3653125
[TBL] [Abstract][Full Text] [Related]
8. Human heart failure: dilated versus familial hypertrophic cardiomyopathy.
Alpert NR; Warshaw DM
Adv Exp Med Biol; 2003; 538():77-87; discussion 87-8. PubMed ID: 15098656
[No Abstract] [Full Text] [Related]
9. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins.
Regitz V; Leuchs B; Bossaller C; Sehested J; Rappolder M; Fleck E
Eur Heart J; 1991 Aug; 12 Suppl D():171-4. PubMed ID: 1915450
[TBL] [Abstract][Full Text] [Related]
10. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
Regitz V; Fleck E
Am J Cardiol; 1992 Jun; 69(19):1574-80. PubMed ID: 1598872
[TBL] [Abstract][Full Text] [Related]
11. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
[TBL] [Abstract][Full Text] [Related]
12. Histological assessment of apoptotic cell death in cardiomyopathies.
Kavantzas NG; Lazaris AC; Agapitos EV; Nanas J; Davaris PS
Pathology; 2000 Aug; 32(3):176-80. PubMed ID: 10968390
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic activity in idiopathic dilated cardiomyopathy. Influence of captopril and hydralazine.
Schofer J; Bleifeld W
Cardiovasc Drugs Ther; 1987 Aug; 1(2):177-81. PubMed ID: 3154321
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic findings in dilated cardiomyopathy and their relation to hemodynamics and catecholamine concentrations in the plasma and myocardium].
Schofer J; Bartels C; Hölscher D; Lierse W; Mathey DG; Reimitz PE; Tews A
Z Kardiol; 1990 Apr; 79(4):302-7. PubMed ID: 2356644
[TBL] [Abstract][Full Text] [Related]
15. A patient with hypertrophic cardiomyopathy accompanied by right ventricular dilation of unknown cause.
Suzuki K; Hasegawa K; Nohara R; Matsumori A; Sasayama S
Jpn Circ J; 1999 Feb; 63(2):137-40. PubMed ID: 10084378
[TBL] [Abstract][Full Text] [Related]
16. Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease.
Hare JM; Walford GD; Hruban RH; Hutchins GM; Deckers JW; Baughman KL
J Am Coll Cardiol; 1992 Nov; 20(6):1318-25. PubMed ID: 1430681
[TBL] [Abstract][Full Text] [Related]
17. Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy.
Pierpont GL; Francis GS; DeMaster EG; Levine TB; Bolman RM; Cohn JN
Am J Cardiol; 1983 Nov; 52(8):1033-5. PubMed ID: 6356860
[TBL] [Abstract][Full Text] [Related]
18. DNA synthetic activity of right and left ventricular biopsy specimens in patients with cardiomyopathy.
Yabe Y; Abe H; Kashiwakura Y
Adv Myocardiol; 1983; 4():163-70. PubMed ID: 6682992
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
Sueyoshi E; Sakamoto I; Uetani M
AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy.
Toyozaki T; Hiroe M; Hasumi M; Horie T; Hosoda S; Tsushima T; Sekiguchi M
Jpn Circ J; 1993 Dec; 57(12):1120-7. PubMed ID: 8283604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
